Ardelyx Inc share price logo

Ardelyx Inc Share Price

NASDAQ: ARDX

Small Cap

$5.30

(+-0.09%)

as on

Ardelyx Inc Stock Performance

as on March 24, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.28
    $5.50
    downward going graph

    0.38%

    Downside

    3.77%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.21
    $8.40
    downward going graph

    39.43%

    Downside

    58.49%

    Upside

    downward going graph

Ardelyx Inc share price movements today

Previous Close
$5.31
Open
$5.46
Volume
3.7M
Day's Low - High
$5.28 - $5.50
52 Week Low - High
$3.21 - $8.40

Ardelyx Inc Historical Returns

1 Month Return
-7.65 %
3 Month Return
-8.45 %
1 Year Return
+ 3.51 %
3 Year Return
+ 30.79 %
5 Year Return
-21.22 %

Ardelyx Inc Stock Fundamentals & Key Indicators

Check Ardelyx Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

0.0127

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

-0.08

EBITDA

-37.9M

Revenue (TTM)

407.3M

Profit Margin

-15.12%

Return On Equity TTM

-36.21%

Ardelyx Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ardelyx Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Ardelyx Inc image
Ardelyx Inc
BUY$1.3B-21.22%NA-15.12%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B125.13%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.56%29.6732.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B56.01%17.6731.41%

Stock Returns calculator for Ardelyx Inc Stock including INR - Dollar returns

The Ardelyx Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ardelyx Inc investment value today

Current value as on today

₹1,13,233

Returns

₹13,233

(+13.23%)

Returns from Ardelyx Inc Stock

₹3,314 (+3.31%)

Dollar Returns*

₹9,919 (+9.92%)

Analyst Recommendation on Ardelyx Inc Stock

Based on 16 analysts

BUY

93.75%

Buy

6.25%

Hold

0.00%

Sell

Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Ardelyx Inc. Average target price of $16.1

Ardelyx Inc Share Price Target

Get share price movements and forecasts by analysts on Ardelyx Inc.

What analysts predicted

67.08%UPSIDE

Target Price

$16.1

Current Price

$5.3

Analyzed by

16 Analysts

Target

$16.10

Ardelyx Inc target price $16.1, a slight upside of 67.08% compared to current price of $5.3. According to 16 analysts rating.

Ardelyx Inc Stock’s Investor Sentiment and Interest

Search interest for Ardelyx Inc Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-52% versus previous 30 day period

Ardelyx Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
56
34
46
73
98
116
74
97
110
125
Gross Profit
48
29
38
63
82
97
61
85
109
111
Operating Income
7
-27
-24
-13
2
8
-36
-14
4
5
EBITDA
9
-25
-21
-10
5
11
-33
-11
5
10
Interest Expense
2
2
4
4
5
5
6
6
5
9
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
6
-28
-26
-16
0
4
-40
-19
0
0
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
6
-28
-26
-16
0
4
-41
-19
0
0
Net Profit Margin
11.76%
-83.82%
-57.62%
-22.47%
-0.82%
4.00%
-55.51%
-19.54%
-0.88%
-0.33%

Ardelyx Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
24
42
2
5
7
10
52
124
333
407
Gross Profit
22
33
2
4
7
9
48
106
283
367
Operating Income
-112
-65
-90
-91
-90
-154
-63
-63
-27
-40
EBITDA
-111
-62
-85
-84
-85
-150
-60
-55
-16
-29
Interest Expense
-
-
3
5
5
4
5
8
20
28
Depreciation
-
2
2
2
1
1
1
1
2
3
Income Before Tax
-112
-63
-91
-94
-94
-158
-67
-65
-38
-60
Income Tax Expense
0
1
0
0
0
0
0
0
0
0
Net Income
-112
-64
-91
-94
-94
-158
-67
-66
-39
-61
Net Profit Margin
-467.77%
-153.19%
-3502.03%
-1797.77%
-1245.71%
-1566.46%
-128.85%
-53.08%
-11.73%
-15.12%

Ardelyx Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-28
-26
-16
0
4
-41
-19
0
0
Operating Cash Flow
-8
-35
-19
0
9
-38
-25
0
20
Investing Cash Flow
-29
-2
23
2
-41
2
34
-50
3
Financing Cash Flow
25
52
1
2
49
1
49
2
0
Change in Cash
-12
14
5
5
17
-34
59
-47
25

Ardelyx Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-64
-91
-94
-94
-158
-67
-66
-39
-61
Operating Cash Flow
-65
-70
-76
-81
-152
-70
-89
-44
-42
Investing Cash Flow
65
-29
23
-31
50
18
-131
-18
-8
Financing Cash Flow
0
103
155
22
82
75
146
106
54
Change in Cash
0
3
102
-90
-18
23
-74
43
3

Global Institutional Holdings in Ardelyx Inc

Funds
Holdings
The Goldman Sachs Group Inc
1.05%
Nuveen, LLC
2.11%
Rock Springs Capital Management LP
0.94%
AQR Capital Management LLC
0.87%
Jane Street Group LLC
0.84%
See all

Insights on Ardelyx Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ARDX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -41.14M → -407.0K (in $), with an average increase of 707.6% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 74.11M → 125.21M (in $), with an average increase of 15.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 10.9% return, outperforming this stock by 9.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ARDX stock has moved down by -8.9%

About Ardelyx Inc

ardelyx is focused on enhancing the way people with renal diseases are treated by developing first-in-class medicines. ardelyx's renal pipeline includes the phase 3 development of tenapanor for the treatment of hyperphosphatemia in people with end-stage renal disease who are on dialysis and rdx013, a potassium secretagogue program for the potential treatment of high potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease. in addition, ardelyx has completed phase 3 development of tenapanor for the treatment of irritable bowel syndrome with constipation and anticipates submitting a new drug application to the u.s. food and drug administration for this indication in the second half of 2018. to efficiently bring its treatments to market, ardelyx is pursing strategic collaborations in the u.s. and other countries, including through established agreements with kyowa hakko kirin in japan, fosun pharma in china and knight therapeutics in canada.
OrganisationArdelyx Inc
Headquarters400 Fifth Avenue, Waltham, MA, United States, 02451
IndustryHealth Technology
CEOMr. Michael G. Raab
E-voting on sharesClick here to vote

Key Management of Ardelyx Inc

Name

Title

Ms. Sue Hohenleitner

Chief Financial Officer

Ms. Caitlin Lowie

Vice President of Corporate Communications & Investor Relations

Mr. James P. Brady

Chief Human Resources Officer

Mr. Eric Duane Foster

Chief Commercial Officer

Dr. John Bishop Ph.D.

Chief Technical Operations Officer

Mr. Michael G. Raab

President, CEO & Director

Mr. Mike Kelliher

Chief Business Officer

Mr. Joseph Reilly

Senior VP of Finance & Principal Accounting Officer

Ms. Elizabeth A. Grammer Esq.

General Counsel

Dr. Laura A. Williams M.D., M.P.H.

Chief Patient Officer & Interim Chief Medical Officer

FAQs

What is Ardelyx Inc share price today?

Ardelyx Inc share price today is $5.3 as on at the close of the market. Ardelyx Inc share today touched a day high of $5.5 and a low of $5.28.

What is the 52 week high and 52 week low for Ardelyx Inc share?

Ardelyx Inc share touched a 52 week high of $8.4 on and a 52 week low of $3.21 on . Ardelyx Inc stock price today i.e. is closed at $5.3,which is 36.90% down from its 52 week high and 65.11% up from its 52 week low.

What is Ardelyx Inc's market capitalisation today?

Ardelyx Inc market capitalisation is $0.00T as on .

How to invest in Ardelyx Inc Stock (ARDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ardelyx Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ardelyx Inc Shares that will get you 0.2830 shares as per Ardelyx Inc share price of $5.3 per share as on March 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Ardelyx Inc Stock (ARDX) from India?

Indian investors can start investing in Ardelyx Inc (ARDX) shares with as little as ₹94.058 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.58 in Ardelyx Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Ardelyx Inc share’s latest price of $5.3 as on March 24, 2026 at 1:29 am IST, you will get 1.8868 shares of Ardelyx Inc. Learn more about fractional shares .

What are the returns that Ardelyx Inc has given to Indian investors in the last 5 years?

Ardelyx Inc stock has given -21.22% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?